AEON Biopharma Inc (AEON)
0.9277
+0.07
(+8.09%)
USD |
NYAM |
Sep 27, 16:00
0.95
+0.02
(+2.40%)
After-Hours: 20:00
AEON Biopharma Research and Development Expense (Annual): 34.75M for Dec. 31, 2022
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
Date | Value |
---|---|
December 31, 2022 | 34.75M |
December 31, 2021 | 25.73M |
Date | Value |
---|---|
December 31, 2020 | 7.319M |
December 31, 2019 | 4.814M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
4.814M
Minimum
2019
34.75M
Maximum
2022
18.15M
Average
16.52M
Median
Research and Development Expense (Annual) Benchmarks
Geovax Labs Inc | 20.72M |
NovaBay Pharmaceuticals Inc | 0.068M |
Palatin Technologies Inc | 22.63M |
iBio Inc | 5.185M |
Theriva Biologics Inc | 14.31M |